Department of Biologics Automation and High-Throughput Technologies, Eli Lilly and Company Biotechnology Center, San Diego, California, United States of America.
Department of Biologics IT, Eli Lilly and Company Biotechnology Center, San Diego, California, United States of America.
PLoS One. 2020 Nov 5;15(11):e0241803. doi: 10.1371/journal.pone.0241803. eCollection 2020.
Immunization-based antibody discovery platforms require robust and effective protocols for the amplification, cloning, expression, and screening of antibodies from large numbers of B-cells in order to effectively capture the diversity of an experienced Ig-repertoire. Multiplex PCR using a series of forward and reverse primers designed to recover antibodies from a range of different germline sequences is challenging because primer design requires the recovery of full length antibody sequences, low starting template concentrations, and the need for all the primers to function under the same PCR conditions. Here we demonstrate several advantages to incorporating RNase H2-dependent PCR (rh-PCR) into a high-throughput, antibody-discovery platform. Firstly, rh-PCR eliminated primer dimer synthesis to below detectable levels, thereby eliminating clones with a false positive antibody titer. Secondly, by increasing the specificity of PCR, the rh-PCR primers increased the recovery of cognate antibody variable regions from single B-cells, as well as downstream recombinant antibody titers. Finally, we demonstrate that rh-PCR primers provide a more homogeneous sample pool and greater sequence quality in a Next Generation Sequencing-based approach to obtaining DNA sequence information from large numbers of cloned antibody cognate pairs. Furthermore, the higher specificity of the rh-PCR primers allowed for a better match between native antibody germline sequences and the VL/VH fragments amplified from single B-cells.
基于免疫的抗体发现平台需要强大且有效的方案来扩增、克隆、表达和筛选大量 B 细胞中的抗体,以有效地捕获经验丰富的免疫球蛋白库的多样性。使用一系列正向和反向引物进行多重 PCR 以从多种不同的种系序列中回收抗体具有挑战性,因为引物设计需要回收全长抗体序列、低起始模板浓度以及所有引物都需要在相同的 PCR 条件下发挥作用。在这里,我们展示了将 RNase H2 依赖性 PCR(rh-PCR)纳入高通量抗体发现平台的几个优势。首先,rh-PCR 将引物二聚体的合成消除到可检测水平以下,从而消除了具有假阳性抗体效价的克隆。其次,通过提高 PCR 的特异性,rh-PCR 引物增加了从单个 B 细胞中回收同源抗体可变区以及下游重组抗体效价的能力。最后,我们证明 rh-PCR 引物在基于下一代测序的方法中提供了更均匀的样本池和更高的序列质量,从而从大量克隆的抗体同源对中获得 DNA 序列信息。此外,rh-PCR 引物的更高特异性允许更好地匹配天然抗体种系序列和从单个 B 细胞中扩增的 VL/VH 片段。